News
-
-
-
PRESS RELEASE
BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS
BioVersys AG announces reporting date for full-year 2024 financial results and event details, including a conference call and webcast on March 26, 2025. The company focuses on developing novel antibacterial products for MDR bacteria -
-
-
PRESS RELEASE
Matador Secondary Private Equity AG: Matador generated a profit of CHF 6.3 million in the 2024 financial year and the net asset value increased by almost 12%
Matador Secondary Private Equity AG reported a profit of CHF 6.3 million and a 12% increase in net asset value for the 2024 financial year. The company shows confidence in future successful financial performance -
PRESS RELEASE
Orell Füssli Ltd: Orell Füssli significantly increases Revenue, EBIT and Net income in 2024
Orell Füssli significantly increases Revenue, EBIT and Net income in 2024. Revenue grows by 8.7%, EBIT increases by 24.5%, net income rises by 19.6% to CHF 17.5 million. Successful strategic projects concluded. Proposed dividend increase to CHF 4.40 per share -
-
-
PRESS RELEASE
Lancement et modification de la deuxième tranche de financement en fonds propres d'un montant 500 K EUR , afin d'accompagner la montée en puissance du site industriel de Revin
CIBOX annonce le lancement de la deuxième tranche de financement en fonds propres pour accompagner la montée en puissance de son site industriel de Revin
